Labeling for Biosimilar and Interchangeable Biosimilar Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 18, 2023
September 18, 2023
54a5f712-03f5-4993-b0d7-6a1c2f261eff
Related Documents
Master Protocols for Drug and Biological Product Development
Guidance DocumentDecember 21, 2023Center for Drug Evaluation and Research
Gluten in Drug Products and Associated Labeling Recommendations; Draft Guidance for Industry
Guidance DocumentDecember 12, 2017Center for Drug Evaluation and Research
Nonproprietary Naming of Biological Products: Update Guidance for Industry
Guidance DocumentMarch 8, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox